Home
AQST
AQST News

Latest Aquestive Therapeutics Inc. (AQST) News on December 18, 2024

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

Benzinga

20 hours ago

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

MT Newswires

a day ago

Cantor Fitzgerald Initiates Aquestive Therapeutics at Overweight With $17 Price Target

Aquestive Therapeutics' (NASDAQ:AQST) investors will be pleased with their favorable 88% return over the last year

Simply Wall St.

a day ago

Aquestive Therapeutics' (NASDAQ:AQST) investors will be pleased with their favorable 88% return over the last year

MT Newswires

16 days ago

Aquestive Therapeutics Receives FDA 'Positive Feedback' for Anaphylm Sublingual Film

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

16 days ago

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?

Insider Monkey

a month ago

Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire

a month ago

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

a month ago

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

a month ago

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a month ago

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

a month ago

Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a month ago

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

a month ago

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Report Preview: What To Expect

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

2 months ago

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need To Know Ahead Of Earnings

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study

TipRanks

2 months ago

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting

GlobeNewswire

2 months ago

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting

Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

2 months ago

Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

GlobeNewswire

2 months ago

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

Benzinga

3 months ago

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

GlobeNewswire

3 months ago

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th

GlobeNewswire

3 months ago

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire

4 months ago

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™

GlobeNewswire

4 months ago

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™

Aquestive Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Aquestive Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

4 months ago

Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates

Zacks

4 months ago

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates

Associated Press Finance

4 months ago

Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$72m last week but retail investors profited the most

Simply Wall St.

5 months ago

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$72m last week but retail investors profited the most

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study

GlobeNewswire

5 months ago

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

GlobeNewswire

5 months ago

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

New Strong Sell Stocks for July 11th

Zacks

5 months ago

New Strong Sell Stocks for July 11th

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire

6 months ago

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Benzinga

6 months ago

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

6 months ago

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years

Simply Wall St.

6 months ago

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years

MT Newswires

6 months ago

Aquestive Therapeutics to Join Russell 3000, Russell 2000 on July 1

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

GlobeNewswire

6 months ago

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

6 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

6 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

6 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

6 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

6 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

6 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

6 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

6 months ago

Enduring role of 'treasuring the past' hailed

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

GlobeNewswire

6 months ago

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

GlobeNewswire

7 months ago

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

5 Small Drug Stocks to Buy From a Recovering Industry

Zacks

7 months ago

5 Small Drug Stocks to Buy From a Recovering Industry

MT Newswires

7 months ago

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

GlobeNewswire

7 months ago

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

7 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

GuruFocus.com

7 months ago

Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Zacks

7 months ago

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

Zacks

7 months ago

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

Associated Press Finance

7 months ago

Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Zacks

7 months ago

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

8 months ago

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

Zacks

8 months ago

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

MT Newswires

8 months ago

Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

8 months ago

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

GlobeNewswire

8 months ago

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

GlobeNewswire

8 months ago

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note

Zacks

9 months ago

Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

GlobeNewswire

9 months ago

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

GlobeNewswire

9 months ago

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know

Zacks

9 months ago

Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

GlobeNewswire

9 months ago

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...

GuruFocus.com

9 months ago

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...

Aquestive Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

9 months ago

Aquestive Therapeutics Announces Proposed Public Offering of Common Stock

Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals

Zacks

9 months ago

Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

GlobeNewswire

9 months ago

Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...

GuruFocus.com

9 months ago

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...

Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results

GuruFocus.com

9 months ago

Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript

Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

9 months ago

Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Aquestive Therapeutics Inc Earnings Call

Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Zacks

9 months ago

Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

9 months ago

Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?

Zacks

9 months ago

Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?

Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know

Zacks

10 months ago

Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know

Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect

Zacks

10 months ago

Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect

Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

GlobeNewswire

10 months ago

Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

10 months ago

Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting

GlobeNewswire

10 months ago

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting

Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts

Zacks

10 months ago

Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts

Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today

Zacks

10 months ago

Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today

Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why

Zacks

a year ago

Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why

Associated Press Finance

a year ago

8x8: Fiscal Q3 Earnings Snapshot

8x8 (NASDAQ:EGHT) Reports Sales Below Analyst Estimates In Q3 Earnings

StockStory

a year ago

8x8 (NASDAQ:EGHT) Reports Sales Below Analyst Estimates In Q3 Earnings

Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference

GlobeNewswire

a year ago

Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference

SOUTHERN CALIFORNIA BANCORP REPORTS NET INCOME OF $4.4 MILLION FOR THE FOURTH QUARTER AND $25.9 MILLION FOR THE FULL YEAR OF 2023

GlobeNewswire

a year ago

SOUTHERN CALIFORNIA BANCORP REPORTS NET INCOME OF $4.4 MILLION FOR THE FOURTH QUARTER AND $25.9 MILLION FOR THE FULL YEAR OF 2023

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Zacks

a year ago

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Trinseo Announces Price Increase for PMMA Cast Sheets in Europe

Business Wire

a year ago

Trinseo Announces Price Increase for PMMA Cast Sheets in Europe

ParkOhio Announces Quarterly Dividend

Business Wire

a year ago

ParkOhio Announces Quarterly Dividend

Share on Social Networks: